BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38403461)

  • 1. Identification of critical process parameters for expansion of clinical grade human Wharton's jelly-derived mesenchymal stromal cells in stirred-tank bioreactors.
    López-Fernández A; Garcia-Gragera V; Lecina M; Vives J
    Biotechnol J; 2024 Feb; 19(2):e2300381. PubMed ID: 38403461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparability exercise of critical quality attributes of clinical-grade human mesenchymal stromal cells from the Wharton's jelly: single-use stirred tank bioreactors versus planar culture systems.
    López-Fernández A; Codinach M; Coca MI; Prat-Vidal C; Castaño J; Torrents S; Aran G; Rodríguez L; Querol S; Vives J
    Cytotherapy; 2024 May; 26(5):418-426. PubMed ID: 37715777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A GMP-compliant manufacturing method for Wharton's jelly-derived mesenchymal stromal cells.
    Chu W; Zhang F; Zeng X; He F; Shang G; Guo T; Wang Q; Wu J; Li T; Zhong ZZ; Liang X; Hu J; Liu M
    Stem Cell Res Ther; 2024 May; 15(1):131. PubMed ID: 38702793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Three-Dimensional Xeno-Free Culture Condition for Wharton's Jelly-Mesenchymal Stem Cells: The Pros and Cons.
    Koh B; Sulaiman N; Fauzi MB; Law JX; Ng MH; Yuan TL; Azurah AGN; Mohd Yunus MH; Idrus RBH; Yazid MD
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and characterization of Wharton's jelly-derived multipotent mesenchymal stromal cells obtained from bovine umbilical cord and maintained in a defined serum-free three-dimensional system.
    Cardoso TC; Ferrari HF; Garcia AF; Novais JB; Silva-Frade C; Ferrarezi MC; Andrade AL; Gameiro R
    BMC Biotechnol; 2012 May; 12():18. PubMed ID: 22559872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual production of human mesenchymal stromal cells and derived extracellular vesicles in a dissolvable microcarrier-based stirred culture system.
    Bandarra-Tavares H; Franchi-Mendes T; Ulpiano C; Morini S; Kaur N; Harris-Becker A; Vemuri MC; Cabral JMS; Fernandes-Platzgummer A; da Silva CL
    Cytotherapy; 2024 Jul; 26(7):749-756. PubMed ID: 38506771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are serum-free and xeno-free culture conditions ideal for large scale clinical grade expansion of Wharton's jelly derived mesenchymal stem cells? A comparative study.
    Swamynathan P; Venugopal P; Kannan S; Thej C; Kolkundar U; Bhagwat S; Ta M; Majumdar AS; Balasubramanian S
    Stem Cell Res Ther; 2014 Jul; 5(4):88. PubMed ID: 25069491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compliance with Good Manufacturing Practice in the Assessment of Immunomodulation Potential of Clinical Grade Multipotent Mesenchymal Stromal Cells Derived from Wharton's Jelly.
    Grau-Vorster M; Rodríguez L; Del Mazo-Barbara A; Mirabel C; Blanco M; Codinach M; Gómez SG; Querol S; García-López J; Vives J
    Cells; 2019 May; 8(5):. PubMed ID: 31117301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wharton's jelly mesenchymal stromal/stem cells derived under chemically defined animal product-free low oxygen conditions are rich in MSCA-1(+) subpopulation.
    Devito L; Badraiq H; Galleu A; Taheem DK; Codognotto S; Siow R; Khalaf Y; Briley A; Shennan A; Poston L; McGrath J; Gentleman E; Dazzi F; Ilic D
    Regen Med; 2014; 9(6):723-32. PubMed ID: 25431909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Platelet Lysate Supports Efficient Expansion and Stability of Wharton's Jelly Mesenchymal Stromal Cells via Active Uptake and Release of Soluble Regenerative Factors.
    Cañas-Arboleda M; Beltrán K; Medina C; Camacho B; Salguero G
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32877987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stirred tank bioreactor culture combined with serum-/xenogeneic-free culture medium enables an efficient expansion of umbilical cord-derived mesenchymal stem/stromal cells.
    Mizukami A; Fernandes-Platzgummer A; Carmelo JG; Swiech K; Covas DT; Cabral JM; da Silva CL
    Biotechnol J; 2016 Aug; 11(8):1048-59. PubMed ID: 27168373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation method and xeno-free culture conditions influence multipotent differentiation capacity of human Wharton's jelly-derived mesenchymal stem cells.
    Corotchi MC; Popa MA; Remes A; Sima LE; Gussi I; Lupu Plesu M
    Stem Cell Res Ther; 2013 Jul; 4(4):81. PubMed ID: 23845279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study on the Umbilical Cord-Mesenchymal Stem Cell Manufacturing Using Clinical-Grade Culture Medium.
    Kurogi H; Takijiri T; Sakumoto M; Isogai M; Takahashi A; Okubo T; Koike T; Yamada T; Nagamura-Inoue T; Sakaki-Yumoto M
    Tissue Eng Part C Methods; 2022 Jan; 28(1):23-33. PubMed ID: 35018815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scaffold-free 3D culturing enhance pluripotency, immunomodulatory factors, and differentiation potential of Wharton's jelly-mesenchymal stem cells.
    Thakur G; Bok EY; Kim SB; Jo CH; Oh SJ; Baek JC; Park JE; Kang YH; Lee SL; Kumar R; Rho GJ
    Eur J Cell Biol; 2022; 101(3):151245. PubMed ID: 35667339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defined three-dimensional culture conditions mediate efficient induction of definitive endoderm lineage from human umbilical cord Wharton's jelly mesenchymal stem cells.
    Al Madhoun A; Ali H; AlKandari S; Atizado VL; Akhter N; Al-Mulla F; Atari M
    Stem Cell Res Ther; 2016 Nov; 7(1):165. PubMed ID: 27852316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Derivation of Mesenchymal Stromal Cells from Ovine Umbilical Cord Wharton's Jelly.
    Carreras-Sánchez I; López-Fernández A; Rojas-Márquez R; Vélez R; Aguirre M; Vives J
    Curr Protoc; 2021 Jan; 1(1):e18. PubMed ID: 33484488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wharton's Jelly Derived-Mesenchymal Stem Cells: Isolation and Characterization.
    Ranjbaran H; Abediankenari S; Mohammadi M; Jafari N; Khalilian A; Rahmani Z; Momeninezhad Amiri M; Ebrahimi P
    Acta Med Iran; 2018 Jan; 56(1):28-33. PubMed ID: 29436792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.
    Batsali AK; Pontikoglou C; Koutroulakis D; Pavlaki KI; Damianaki A; Mavroudi I; Alpantaki K; Kouvidi E; Kontakis G; Papadaki HA
    Stem Cell Res Ther; 2017 Apr; 8(1):102. PubMed ID: 28446235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Umbilical cord derived mesenchymal stromal cells in microcarrier based industrial scale culture sustain the immune regulatory functions.
    Kurogi H; Takahashi A; Isogai M; Sakumoto M; Takijiri T; Hori A; Furuno T; Koike T; Yamada T; Nagamura-Inoue T; Sakaki-Yumoto M
    Biotechnol J; 2021 Jun; 16(6):e2000558. PubMed ID: 33545746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wharton's jelly mesenchymal stem cell-based or umbilical vein endothelial cell-based serum-free coculture with cytokines supports the ex vivo expansion/maintenance of cord blood hematopoietic stem/progenitor cells.
    Li Q; Zhao D; Chen Q; Luo M; Huang J; Yang C; Wang F; Li W; Liu T
    Stem Cell Res Ther; 2019 Dec; 10(1):376. PubMed ID: 31806004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.